A Case of Acute Inflammatory Demyelinating Polyradiculoneuropathy in a Patient with Systemic Lupus Erythematosus

Jeong-Won Lee; Ji-Hyoun Kang; Hyoung-Ju Hong; Sun-Mi Ju; Kyung-Eun Lee; Lihui Wen; Dong-Jin Park; Tae-Jong Kim; Yong-Wook Park; Shin-Seok Lee

doi:10.4078/jrd.2014.21.3.143

Journal List > J Rheum Dis > v.21(3) > 1064108

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Lee, Kang, Hong, Ju, Lee, Wen, Park, Kim, Park, and Lee: A Case of Acute Inflammatory Demyelinating Polyradiculoneuropathy in a Patient with Systemic Lupus Erythematosus

Case Report

J Rheum Dis 2014;21(3):143-146.

Published online: 31 October 2014

DOI: https://doi.org/10.4078/jrd.2014.21.3.143

A Case of Acute Inflammatory Demyelinating Polyradiculoneuropathy in a Patient with Systemic Lupus Erythematosus

Jeong-Won Lee, Ji-Hyoun Kang, Hyoung-Ju Hong, Sun-Mi Ju, Kyung-Eun Lee, Lihui Wen, Dong-Jin Park, Tae-Jong Kim, Yong-Wook Park, Shin-Seok Lee

Department of Rheumatology, Chonnam National University Medical School, Gwangju, Korea

Corresponding to: Shin-Seok Lee, Department of Rheumatology, Chonnam National University Medical School, 42, Jebong-ro, Dong-gu, Gwangju 501-757, Korea. E-mail: shinseok@chonnam.ac.kr

Received 7 June 2013 Revised 24 June 2013 Accepted 26 June 2013

This is a Free Access article, which permits unrestricted non-commerical use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Neuropsychiatric manifestations in patients with systemic lupus erythematosus are fairly common, with a prevalence of 37∼95%. Among 19 neuropsychiatric manifestations, acute inflammatory demyelinating polyradiculoneuropathy (AIDP) is quite rare, and is characterized by progressive, symmetric muscle weakness accompanied by absent or depressed deep tendon reflexes. Generally, plasma exchange and intravenous immunoglobulin are the main treatment modalities. Here, we report a case of AIDP in a 29-year-old SLE patient, who was fully recovered with a treatment of high-dose glucocorticoid and immunosuppressive agents. Ours case suggests that AIDP should be treated differently in SLE patients to avoid disastrous results.

Keywords: Systemic lupus erythematosus, Central nervous system, Polyradiculoneuropathy

REFERENCES

1. Wang M, Gladman DD, Ibañez D, Urowitz MB. Longterm outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012; 64:833–7.

2. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999; 42:599–608.

3. Bertsias GK, Boumpas DT. Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol. 2010; 6:358–67.

4. Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010; 69:2074–82.

5. Firestein GS, Budd RC, Gabriel SE, Mclnnes IB, O'Dell JR. Kelley's textbook of rheumatology. 9th ed.p. 1297. Philadelphia: Elsevier/Saunders;2013.

6. Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol. 2004; 148:200–5.

7. Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barré syndrome. Arch Neurol. 2001; 58:913–7.

8. Labrador-Horrillo M, Martinez-Valle F, Gallardo E, Rojas-Garcia R, Ordi-Ros J, Vilardell M. Anti-ganglioside antibodies in patients with systemic lupus erythematosus and neurological manifestations. Lupus. 2012; 21:611–5.

9. Lo YL. Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve. 2007; 36:615–27.

10. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med. 2012; 366:2294–304.

11. Hughes RA, Wijdicks EF, Barohn R, Benson E, Cornblath DR, Hahn AF, et al. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003; 61:736–40.

12. Bartolucci P, Bréchignac S, Cohen P, Le Guern V, Guillevin L. Adjunctive plasma exchanges to treat neuropsychiatric lupus: a retrospective study on 10 patients. Lupus. 2007; 16:817–22.

13. Milstone AM, Meyers K, Elia J. Treatment of acute neuropsychiatric lupus with intravenous immunoglobulin (IVIG): a case report and review of the literature. Clin Rheumatol. 2005; 24:394–7.

14. Tokunaga M, Saito K, Kawabata D, Imura Y, Fujii T, Nakayamada S, et al. Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Ann Rheum Dis. 2007; 66:470–5.

15. Matsuki Y, Hidaka T, Matsumoto M, Fukushima K, Suzuki K. Systemic lupus erythematosus demonstrating serum anti-GM1 antibody, with sudden onset of drop foot as the initial presentation. Intern Med. 1999; 38:729–32.

Table 1.

The nerve conduction studies show absent F-waves in both arms and absent both H reflex

	F-Latency (ms)	Normal range (ms)	Left-Right F-Latency (ms)	Normal range (ms)
Left Median (Abd Poll Brev)		＜33		＜2.2
Right Median (Abd Poll Brev)		＜33		＜2.2
Left Peroneal (EDB)	45.58	＜60	1.92	＜5.1
Right Peroneal (EDB)	47.50	＜60	1.92	＜5.1
Left Tibial (Abd Hallucis)	45.58	＜61	1.75	＜5.7
Right Tibial (Abd Hallucis)	47.33	＜61	1.75	＜5.7
Left Ulnar (Abd Dig Min)		＜36		＜2.5
Right Ulnar (Abd Dig Min)		＜36		＜2.5

	H-Latency (ms)	Left-Right H-Latency (ms)	Normal range (ms)
Left Tibial (Gastrocnemius)			＜2.0
Right Tibial (Gastrocnemius)			＜2.0

ms: mili second, Abd Poll Brev: Abductor pollicis brevis, EDB: Extensor digitorum brevis, Abd Hallucis: Abductor Hallucis, Abd Dig Min: Abductor digiti minimi.

TOOLS

Similar articles